Filarial nematode secreted product ES-62 is an anti-inflammatory agent: Therapeutic potential of small molecule derivatives and ES-62 peptide mimetics

被引:43
|
作者
Harnett, W
Harnett, MM
机构
[1] Univ Strathclyde, Dept Immunol, Glasgow G4 0NR, Lanark, Scotland
[2] Univ Glasgow, Div Immunol Infect & Inflammat, Glasgow, Lanark, Scotland
基金
英国惠康基金;
关键词
ES-62; filarial nematodes; inflammation; signal transduction;
D O I
10.1111/j.1440-1681.2006.04400.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1. The 'hygiene hypothesis' postulates that the recent increased incidence of allergic or autoimmune diseases (e.g. asthma, type I diabetes) in the West reflects an absence of appropriate priming of the immune response by infectious agents, such as parasitic worms, during childhood. 2. Consistent with this, it has long been recognized that several autoimmune disorders, such as rheumatoid arthritis (RA), a T helper (Th) 1-mediated autoimmune disease characterized by excess production of pro-inflammatory cytokines, such as tumour necrosis factor-a, exhibit reduced incidence and severity in geographical regions with high parasite load, suggesting that environmental factors may subtly alter disease progression. 3. Infection with worms also appears to suppress Th2-biased inflammatory disorders, such as asthma, because there also appears to be an inverse correlation between parasite load and atopy. This is perhaps more surprising, given that helminths often induce strong Th2-type immune responses characterized by release of specific cytokines, such as interleukin (IL)-4, IL-5 and IL-13. 4. Therefore, these findings suggest that the co-evolution of helminths with hosts, which has resulted in the ability of worms to modulate inflammatory responses in order to promote parasite survival, may also have generated a predisposition for the host to develop autoimmunity and allergy in the absence of infection. 5. The mechanisms underlying such immunomodulation are not clear, but appear to involve the release of parasite-derived molecules that allow the worms to modulate or evade the host immune response by a number of mechanisms, including skewing of cytokine responses and the induction of T regulatory cells. 6. In the present review we discuss the properties of one such filarial nematode-derived immunomodulatory molecule, namely ES-62, its anti-inflammatory action and the therapeutic potential of small molecule derivatives and peptides that mimic its action.
引用
收藏
页码:511 / 518
页数:8
相关论文
共 50 条
  • [31] The filarial nematode product, ES-62 targets IL-22 to mediate protection in collagen-induced arthritis
    Pineda, Miguel
    Harnett, William
    Al-Riyami, Lamyaa
    Harnett, Margarett
    JOURNAL OF IMMUNOLOGY, 2013, 190
  • [32] The filarial nematode product, ES-62, targets IL-22 to mediate protection in collagen-induced arthritis
    Pineda, M. A.
    Harnett, W.
    Harnett, M. M.
    IMMUNOLOGY, 2014, 143 : 57 - 57
  • [33] The Carbohydrate-linked Phosphorylcholine of the Parasitic Nematode Product ES-62 Modulates Complement Activation
    Ahmed, Umul Kulthum
    Maller, N. Claire
    Iqbal, Asif J.
    Al-Riyami, Lamyaa
    Harnett, William
    Raynes, John G.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2016, 291 (22) : 11939 - 11953
  • [34] Failure of ES-62 to inhibit T-helper type 1 responses to other filarial nematode antigens
    Al-Riyami, L.
    Egan, C. A.
    Bradley, J. E.
    Lustigman, S.
    Harnett, W.
    PARASITE IMMUNOLOGY, 2008, 30 (05) : 304 - 308
  • [35] A novel therapeutic approach targeting articular inflammation using the filarial nematode-derived phosphorylcholine-containing glycoprotein ES-62
    McInnes, IB
    Leung, BP
    Harnett, M
    Gracie, JA
    Liew, FY
    Harnett, W
    JOURNAL OF IMMUNOLOGY, 2003, 171 (04): : 2127 - 2133
  • [36] Inhibition of FcεRI-mediated mast cell responses by ES-62, a product of parasitic filarial nematodes
    Alirio J Melendez
    Margaret M Harnett
    Peter N Pushparaj
    WS Fred Wong
    Hwee Kee Tay
    Charles P McSharry
    William Harnett
    Nature Medicine, 2007, 13 : 1375 - 1381
  • [37] Inhibition of FcεRI-mediated mast cell responses by ES-62, a product of parasitic filarial nematodes
    Melendez, Alirio J.
    Harnett, Margaret M.
    Pushparaj, Peter N.
    Wong, Ws Fred
    Tay, Hwee Kee
    McSharry, Charles P.
    Harnett, William
    NATURE MEDICINE, 2007, 13 (11) : 1375 - 1381
  • [38] T-helper Type 1 Responses to the BCG Vaccine Component PPD in Mice Are Unaffected by the Filarial Nematode Immunomodulatory Molecule ES-62
    Al-Riyami, L.
    Wilson, E. H.
    Watson, C. A.
    Harnett, W.
    JOURNAL OF PARASITOLOGY, 2009, 95 (05) : 1201 - 1204
  • [39] Designing Anti-inflammatory Drugs from Parasitic Worms: A Synthetic Small Molecule Analogue of the Acanthocheilonema viteae Product ES-62 Prevents Development of Collagen-Induced Arthritis
    Al-Riyami, Lamyaa
    Pineda, Miguel A.
    Rzepecka, Justyna
    Huggan, Judith K.
    Khalaf, Abedawn I.
    Suckling, Colin J.
    Scott, Fraser J.
    Rodgers, David T.
    Harnett, Margaret M.
    Harnett, William
    JOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (24) : 9982 - 10002
  • [40] Site-specific glycoproteomic characterization of ES-62: The major secreted product of the parasitic worm Acanthocheilonema viteae
    North, Simon J.
    Botchway, Kwamina
    Doonan, James
    Lumb, Felicity E.
    Dell, Anne
    Harnett, William
    Haslam, Stuart M.
    GLYCOBIOLOGY, 2019, 29 (08) : 562 - 571